CIK 0001783328
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
TScan Therapeutics, Inc.
Sign in to watch- Ticker
- TCRX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 825282075
- Phone
- +1 857-399-9500
- Business address
- 830 WINTER STREET, WALTHAM, MA, 02451
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-10-01 | MacBeath Gavin Chief Executive Officer | Grant or award | +1,000,000 | 1,049,767 | ||
| 2026-01-20 | MacBeath Gavin Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +1,165,000 | 1,165,000 | ||
| 2025-01-03 | MacBeath Gavin Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +800,000 | 800,000 | ||
| 2024-01-12 | MacBeath Gavin Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +160,000 | 160,000 | ||
| 2023-06-13 | MacBeath Gavin Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +1,121,300 | 1,121,300 | ||
| 2023-02-02 | MacBeath Gavin See Remarks | Grant or award · Stock Option (Right to Buy) | +40,000 | 40,000 | ||
| 2022-07-25 | MacBeath Gavin See Remarks | Grant or award · Stock Option (Right to Buy) | +100,000 | 100,000 | ||
| 2022-01-18 | MacBeath Gavin Chief Scientific Officer | Grant or award · Stock Option (Right to Buy) | +140,000 | 140,000 | ||
| 2021-09-21 | MacBeath Gavin Chief Scientific Officer | Purchase | +57 | $6.19 | $353 | 49,767 |
| 2021-09-20 | MacBeath Gavin Chief Scientific Officer | Purchase | +4,943 | $6.22 | $31K | 49,710 |
Page 1 of 1 · 10 trades